Recent News

Carolina receives $10 million commitment from the Pope Foundation

Carolina receives $10 million commitment from the Pope Foundation

The donation will provide support for UNC Lineberger Comprehensive Cancer Center, UNC Horizons, the track and field program, and the Philosophy, Politics and Economics Program.

Carolina receives $10 million commitment from the Pope Foundation - Read More…

UNC scientists create better laboratory tools to study cancer’s spread

UNC scientists create better laboratory tools to study cancer’s spread

In the journal Nature Biomedical Engineering, UNC Lineberger’s Andrew Wang, MD, and colleagues report they have developed tissue-engineered models for cancer metastases that reflect the microenvironment around tumors that promotes their growth. They believe their models, which were developed to study colorectal cancer that had spread to the liver and lung, will help scientists studying why cancers tend to spread to certain organs rather than others.

UNC scientists create better laboratory tools to study cancer’s spread - Read More…

Cigarillo packaging can influence product perception, study finds

Cigarillo packaging can influence product perception, study finds

Researchers led by UNC Lineberger's Adam Goldstein, MD, and Clare Meernik, MPH, surveyed 2,664 young adults who were current users, never users, or past users of little cigars and cigarillos, finding cigarillo packs with colors and containing a flavor descriptor were rated more positively for taste and smell. Health warnings didn’t fully mitigate the draw of the packaging.

Cigarillo packaging can influence product perception, study finds - Read More…

Scientists evaluate strategy to treat aggressive breast cancer once it's spread to the brain

Scientists evaluate strategy to treat aggressive breast cancer once it's spread to the brain

UNC Lineberger's Carey Anders, MD, and Amanda Van Swearingen, PhD, senior research specialist at UNC Lineberger, presented preclinical findings at the American Association for Cancer Research Annual Meeting 2018 about a potential promising strategy for triple negative breast cancer brain metastases. They studied the PARP inhibitor, niraparib, in three models of triple negative breast cancer with alteration and loss-of-function changes in the BRCA1 gene.

Scientists evaluate strategy to treat aggressive breast cancer once it's spread to the brain - Read More…